Adherex Technologies Inc
(AMEX:ADH)|
0.03 -0.01 (-25.00%) Dec 04 - Close |
|
|
|
After-Hours 0.03 0.00 (0.00%) Thu, 4 Dec 2008 7:40 PM
- Compare ADH with:
- View: Line | Candlestick
Company Profile
Adherex Technologies Inc
4620 Creekstone Drive
Durham, -2 27703
United States - Map
Phone: (919) 484-8484
Fax: (919) 484-8001
Website: www.adherex.com
CEO: Dr. William P. Peters, M.D., Ph.D.
Employees: 29
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
cancer and tumor targeting biopharmaceutical comp
A development stage biopharmaceutical company focused on cancer therapeutics with preclinical and clinical product candidates.
Recent news for ADH
-
ADHEREX TECHNOLOGIES INC Financials
EDGAR Online Financials - 11 hours ago
-
ADHEREX TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 12 at 5:09 ET
-
Adherex Reports Third Quarter 2008 Financial Results
Marketwire - Nov 12 at 8:37 ET
-
Adherex to Present at Windhover's Therapeutic Area Partnerships Meeting
Marketwire - Oct 29 at 7:30 ET
-
ADHEREX TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Aug 13 at 2:56 ET
-
Adherex Reports Second Quarter 2008 Financial Results
Marketwire - Aug 13 at 7:30 ET
-
Adherex Announces Updated ADH-1 Chemotherapy Combination Data in Melanoma
Marketwire - Jun 02 at 7:30 ET
-
EDGAR Online - May 19 at 2:21 ET
-
Adherex Announces ASCO Abstract of ADH-1 in Melanoma
Marketwire - May 19 at 7:30 ET
-
Adherex Announces Publication of ADH-1 Study in Cancer Research
Marketwire - May 15 at 7:30 ET
Top members owning ADH
-
Top 94%
-60.61%3m:
-60.61%YTD: